Nicholas Ballasy over at Just The News is reporting that 10 members of the NIH panel responsible for setting the agency’s guidelines for treating COVID-19 are, in one way or another, pocketing a check from companies peddling COVID cures. 8 of the lucky buggers are being enriched by pharmaceutical giant Gilead Sciences, makers of the drug remdesivir.